The Impella® is U.S. FDA-approved percutaneous heart pump technology that provides short-term support in heart failure and those undergoing high-risk PCI. Inserted via a minimally invasive percutaneous procedure and positioned across the aortic valve, it functions as a microaxial pump, unloading the LV by drawing blood into the aorta and improving systemic flow. — At CardioVisual, we simplify complex cardiometabolic information into engaging, visual content for clinicians and patients alike, emp

Impella RP Right Heart Pump 🫀 This clip is one of our many about cardiac interventions on our website heart.medicalvisual.com! In the setting of cardiogenic shock, the heart struggles to pump enough blood to meet the body’s demands. When the right ventricle fails, it can’t pump blood to the lungs effectively, leading to backup in the veins (increased central venous pressure) and inadequate oxygen delivery to the body (low cardiac index). The Impella RP right heart pump steps in to temporarily t

The Impella device is used to treat cardiogenic shock and to protect the patient during percutaneous coronary intervention (PCI). The Impella is implanted in the left ventricle and propulses blood from the LV to the aorta, off loading the left ventricle. The catheters used can have a size/flow range from 3.5 lpm to 5.5 lpm. Additionally, there is now a right ventricular catheter that can assist patients with RV failure. This device is considered the gold standard for treating cardiogenic shock u